Filing Flows

Filing Flows › Timken (TKR) › Guidance & outlook

Timken (TKR) guidance and outlook

Timken (TKR) raised its guidance on Nov 4, 2026: EPS $4.05–$4.20 for FY2026; EPS $4.05–$4.20 for FY2026; EPS $4.05 for FY2026. Timken's 10-Q filed Nov 4, 2026 makes 10 forward-looking statements.

Guidance and outlook

Timken: what its forward-looking statements are about (10-Q filed 2026-11-04)Timken: what its forward-looking statements are about (10-Q filed 2026-11-04)Demand6Other4
10 statements; tone +0.40 (−1 all cautious, +1 all confident); 0 hedged.
Timken: outlook statements against the filing beforeTimken: outlook statements against the filing beforeConfident5Cautious1

Latest guidance

MetricPeriodRangeChange
EPSFY2026$4.05–$4.20raised
EPSFY2026$4.05–$4.20raised
EPSFY2026$4.05raised

From the earnings release filed Nov 4, 2026 (8-K on EDGAR).

Forward-looking statements, 10-Q filed Nov 4, 2026

Timken's latest quarter

Timken, Q3 2026: revenue $1.2B (+5% year over year), operating margin 13.7%, net earnings $93.8M, operating cash flow $256M. The chart follows the revenue to costs, profit and cash.

Questions

Did Timken raise or lower its guidance?

Timken (TKR) raised its guidance on Nov 4, 2026: EPS $4.05–$4.20 for FY2026; EPS $4.05–$4.20 for FY2026; EPS $4.05 for FY2026.

What does Timken expect?

The Company intends to expand into new and existing markets by leveraging its collective knowledge of materials science, friction management and power transmission to create value for Timken customers. The Company intends to grow in attractive market sectors around the world, emphasizing those spaces that are highly fragmented, demand high service and value the reliability and efficiency offered by Timken products. The Company also targets applications that offer significant aftermarket demand, thereby providing product and services revenue throughout the equipment’s lifetime.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.